Login / Signup

Gastrointestinal involvement attenuates COVID-19 severity and mortality.

Alexandra E LivanosDivya JhaFrancesca CossariniAna Silvia Gonzalez-ReicheMinami TokuyamaTeresa A Aydillo GomezTommaso Lorenzo ParigiIrene RamosKatie DunleavyBrian LeeRebekah DixonSteven T ChenGustavo Martinez-DelgadoSatish NagulaHuaibin Mabel KoBenjamin Scott GlicksbergGirish Nitin NadkarniElisabet PujadasJason ReidySteven NaymagonAri M GrinspanJawad AhmadMichael TankelevichRonald GordonKeshav SharmaJane HouldsworthGraham J BrittonAlice Chen-LiawMatthew P SpindlerTamar PlittPei WangAndrea CeruttiJeremiah J FaithJean Frederic ColombelEphraim KenigsbergCarmen A ArgmannMiriam MeradSacha GnjaticNoam HarpazSilvio DaneseCarlos Cordon-CardoAdeeb H RahmanNikhil A KumtaAlessio AghemoFrancesca PetraliaHarm van BakelAdolfo García-SastreSaurabh Mehandru
Published in: medRxiv : the preprint server for health sciences (2020)
Intestinal infection with SARS-CoV-2 is associated with a mild inflammatory response and improved clinical outcomes.
Keyphrases
  • sars cov
  • inflammatory response
  • respiratory syndrome coronavirus
  • lipopolysaccharide induced
  • cardiovascular events
  • lps induced
  • toll like receptor
  • type diabetes